Close
Smartlab Europe
Achema middle east

News

Australia Offers A Nasal Vaccine To Guard Against COVID-19

Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal vaccination system that promotes strong lung resistance and tolerance against the SARS-CoV-2 coronavirus. The newly developed vaccine strategy, which was successfully tested in mice and...

NICE Offers Historical Clinical Funding To Kidney Cancer UK

Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and Care Excellence (NICE) to create the first-ever clinical guidelines for the disease. The organisation conducted an...

Big Pharma May Need To Report State Deals In WHO Crisis

Under new regulations that would oversee a pandemic agreement approved by the World Health Organization, which Reuters has reviewed, pharmaceutical companies might be required to disclose prices and agreements for any medications they produce to battle future global health...

Edible Sensor Monitors HIV Patients Antiretroviral Doses

A new ingestible sensor system that was put to the test in an interventional clinical trial gave HIV patients real-time antiretroviral dosage information, helping them to better manage their infection. The Proteus Digital Health Feedback (PDHF) information technology system kept...

In Britain, The ABPI Sets Out A Clear Antimicrobial Goal

The Association of the British Pharmaceutical Industry (ABPI) has reemphasized its message to the industry about the development of new antibiotics on the eve of World Antibiotic Awareness Week. Antibiotic-resistant illnesses are thought to have caused 1.2 million deaths...

Oxford Scientists Have Found Main Origin of Type 2 Diabetes

The root cause of type 2 diabetes has been clarified by a new study, which shows that elevated blood glucose alters the metabolism of pancreatic cells. Approximately 415 million people worldwide have diabetes. Nearly five million people in the UK...

First Implanted Pump Uses Chemotherapy To Treat Brain Cancer

In a Phase I study that was recently published in the journal Lancet Oncology, it was shown that the first implantable pump system for individuals suffering from brain cancer could successfully kill reoccurring glioblastoma (GBM) tumour cells by continuously...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »